A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
about
Impact of MDM2 309T>G polymorphism on sarcomagenesisThe RASSF1A tumor suppressor regulates XPA-mediated DNA repairRole of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis.Clinical utility of RASSF1A methylation in human malignancies.Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks.The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy.Hippo pathway and protection of genome stability in response to DNA damage.Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.Ras signaling through RASSF proteins.RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors.The RASSF6 tumor suppressor protein regulates apoptosis and the cell cycle via MDM2 protein and p53 protein.The differential effects of wild-type and mutated K-Ras on MST2 signaling are determined by K-Ras activation kinetics.Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth.p53 shades of Hippo.MST2 kinase suppresses rDNA transcription in response to DNA damage by phosphorylating nucleolar histone H2B.
P2860
Q28608667-59B3E468-342A-4D07-BDAE-C081B3842BCDQ34968548-9E5F589A-DBBA-4BDC-8ABB-40C3AF8F1D76Q35102439-7E38614C-CF47-4DA1-A62C-9D0BB59EDAE4Q35856673-9AC6CA04-7C52-4B90-844E-64067475C79EQ35909621-386FA99F-5D78-490B-91B7-B2E476A4A10DQ36185758-04567B76-B65A-4892-8231-6500D03264C2Q38171966-A9949B7A-2C32-41AF-AA00-EC06F228E70BQ38647812-ED1F7954-055E-4A0E-8311-56E3851EAB7BQ38821010-18CA089C-0B78-4824-89DD-E36B31A39938Q38862017-DC31F517-FFA9-4754-A80B-ADA0B5E5DD4CQ38956821-C7DD5E93-A4D1-4AA7-95CE-C17374646C36Q39065640-B94A1FB2-5ACC-4F87-899A-16DB5AC16A76Q39100434-29F1F1BF-C5C3-45C3-B134-411FE4395D83Q39185488-52B84EBB-1F9A-424A-9DAF-F16E181B454CQ46468034-911838B8-14CF-414A-AF1E-E6B42DC6B1FFQ47116225-7F3D2C19-2AB7-4D77-B0F5-E089E535D6D3Q47850800-A06404B5-3F74-42F5-8DA9-003EEFEFCDFBQ54107827-EC980F26-D8B4-4FD9-98CF-936265D2A228
P2860
A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A RASSF1A polymorphism restric ...... onset of soft tissue sarcoma.
@ast
A RASSF1A polymorphism restric ...... onset of soft tissue sarcoma.
@en
type
label
A RASSF1A polymorphism restric ...... onset of soft tissue sarcoma.
@ast
A RASSF1A polymorphism restric ...... onset of soft tissue sarcoma.
@en
prefLabel
A RASSF1A polymorphism restric ...... onset of soft tissue sarcoma.
@ast
A RASSF1A polymorphism restric ...... onset of soft tissue sarcoma.
@en
P2093
P2860
P1433
P1476
A RASSF1A polymorphism restric ...... onset of soft tissue sarcoma.
@en
P2093
Anna Grawenda
Elisabeth E Bond
Eric O'Neill
Gareth L Bond
Garth Hamilton
Karen S Yee
Lukasz Grochola
Peter Wurl
P2860
P304
P356
10.1158/0008-5472.CAN-11-2906
P407
P577
2012-03-02T00:00:00Z